iBio Inc (IBIO)
1.98
+0.13
(+7.03%)
USD |
NYAM |
May 02, 13:55
iBio Gross Profit (TTM)
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
June 30, 2021 | 1.373M |
March 31, 2021 | 1.89M |
December 31, 2020 | 1.628M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 |
Date | Value |
---|---|
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.8404M |
June 30, 2011 | 0.5201M |
March 31, 2011 | 0.176M |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.1334M |
December 31, 2009 | 0.2939M |
September 30, 2009 | 0.478M |
June 30, 2009 | 0.6758M |
March 31, 2009 | 0.5969M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.373M
Minimum
Jun 2021
1.89M
Maximum
Mar 2021
1.630M
Average
1.628M
Median
Dec 2020
Gross Profit (TTM) Benchmarks
Lixte Biotechnology Holdings Inc | -- |
PAVmed Inc | -3.969M |
Avalo Therapeutics Inc | 0.64M |
Imunon Inc | -- |
Ocugen Inc | -- |